On this week’s Tech Nation, Dr. Jonathan Javitt from NeuroRX Pharma talks about a scientific discovery which lingered for nearly two decades in some 70 boxes in deep storage – it’s now being tested as a treatment for COVID-19. Then Rick Carreon, the CEO of ImpediMed, tells us about a technology developed in the 1990’s for research purposes. Today it’s approved for the early detection of lymphedema following breast cancer – and early intervention can stop its progression.

On this week’s Tech Nation, Wharton Marketing Professor, Jonah Berger, follow his earlier books, “Contagious” and “Invisible Influence”. His latest is “The Catalyst – How To Change Anyone’s Mind”. Then on BioTech Nation, using viruses to our benefit. That’s the idea from Aspa Therapeutics. Dr. Eric David described Aspa’s approach to deliver essential treatment for the rare genetic condition of Canavan’s Disease.

On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …
Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.

On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …
Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.

On this week’s Tech Nation, Moira speaks with Neuroscientist Daniel Levitin about his book “Successful Aging … A Neuroscientist Explores the Power and Potential of Our Lives”. And Dr. Cameron Turtle from Eidos Therapeutics tells us that of the 6 Million Americans living with the medical condition known as Heart Failure, several hundred thousand have a special type, which was thought to be rare, but is being underdiagnosed. It’s known by its initials: ATTR. Eidos is working on a treatment

Sarah Frier, technology journalist with Bloomberg News, and author of the Financial Times’ Book of the Year, “No Filter: The Inside Story of Instagram”. And Victor Hwang, a former Silicon Valley venture capitalist and founder of Right to Start. He’s also the author of “The Rainforest – The Secret to Building the Next Silicon Valley.”

On this week’s Tech Nation, Moira speaks with David Quammen is the author of “Spillover: Animal Infections and the Next Human Pandemic”, his 2012 book which sounds oh-so familiar today. There are gorillas, chimpanzees and monkeys, birds and rats and, yes, bats. Then a San Diego company working on a simple blood test for early stage Lung Cancer. With 2/3’s of patients initially diagnosed at stage 4, Chris Hibberd, the CEO of Nucleix, tells us how they did it, their focus on for bladder cancer and 12 other cancers, and how its science fueled a Law and Order episode.

On this week’s Tech Nation, Moira speaks with Sandy Fershee, the Lab Director for D-Ford Detroit at Ford Motor Company. They talk about the latest features for the best-selling vehicle on the road - the F-150 pick-up truck from Ford. They talk about the latest design updates, and how Ford went about it.

Then Brian Culley, the CEO of Lineage Cell Therapeutics in San Diego, explains cell therapy in plain words. They’re working on dry age-related macular degeneration and spinal cord injury, and they also have a new idea to create life-time immunity against COVID-19.

Neuroscientist and psychologist Lisa Feldman Barrett. She gives us “7½ Lessons about the Brain” and has some surprises – there is no “reptilian” part of your brain … it’s just a myth. Then in biotech – treatments to fight diseases caused by inflammation – Dr. Jim Woody, the CEO of 180 Life Sciences talks about their pipeline of drugs, as well as their lead work in clinical trials now – it’s for Dupuytren’s Contracture, affecting one out of 25 people in Europe and North America.

Computer Scientist Dr. Lorien Pratt about “Link … How Decision Intelligence Connects Data, Actions, and Outcomes for a Better World.” Then Dr. Seth Lederman, the CEO of Tonix Pharmaceuticals, tells us about how PTSD affects the brain, its relation to sleep, and how it may treated some 9 years after the initial trauma. If you have experienced trauma, and PTSD, you may qualify for one of their clinical studies.